Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 50090-6833

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 50090-6833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol-structure. (Labetalol Structure)

Labetalol-structure. (Labetalol Structure)
Chemical structure diagram of Labetalol Hydrochloride, showing its molecular components including aromatic rings, hydroxyl groups, an amide group, and hydrochloride salt.*
FDA Label Image

Label Image (Lbl500906833)

Label Image (Lbl500906833)
Labetalol Hydrochloride 300 mg film-coated tablets in a bottle label by A-S Medication Solutions. The label states each tablet contains Labetalol Hydrochloride USP 300 mg and includes storage instructions to keep at 68 to 77 degrees Fahrenheit. The package contains 90 tablets and displays the product NDC 50090-6833-1.*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table comparing adverse event frequencies (%) in patients taking Labetalol Hydrochloride, Placebo, Propranolol, and Metoprolol. The table categorizes side effects by body systems such as gastrointestinal, nervous, cardiovascular, respiratory, skin, and special senses, listing specific symptoms and their occurrence rates across the four groups.*
FDA Label Image

Table2 (Table2)

Table2 (Table2)
Data table presenting the daily dose of Labetalol Hydrochloride in milligrams (200 to 2400 mg) alongside patient counts and percentages experiencing various side effects such as dizziness, fatigue, nausea, vomiting, dyspepsia, paresthesias, nasal stuffiness, ejaculation failure, impotence, and edema.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.